New Aquapheresis treatment can replace expensive diuretic medications
The Specialty Hospital of Washington is the first Long Term Acute Care Hospital in the metropolitan area to offer Aquapheresis™, a tremendous benefit for congestive heart failure (CHF) patients with fluid overload who do not respond to diuretics. Fluid overload is a distressing symptom of CHF, which is responsible for more than one million hospitalizations each year.
If not managed, fluids begin to accumulate in the extremities eventually causing congestion in the lungs, and making breathing difficult. The usual treatment for fluid overload is therapy with a diuretic medicine. Approximately 40 percent of CHF patients do not respond to diuretics. Using the product Aquapheresis, patients are connected to a small medical device called an Aquadex FlexFlow™, which dramatically and safely reduces fluid levels in a very short time. A highly acclaimed clinical study published last year in the Journal of American College of Cardiology, confirmed the effectiveness and many benefits of the new Aquapheresis technology.
For more information about Aquapheresis, a unique and simplified form of ultrafiltration, click on the following link from CHF Solutions, the manufacturers of Aquadex FlexFlowTM: http://www.gambro.com/
About SHW
The Specialty Hospital of Washington is the premier long term acute care hospital in the Washington DC area, and offers a preferred, cost effective alternative to long term stays in typical general hospital intensive care units. SHW is a fully accredited and highly rated hospital providing extraordinary care for its patients at both its Capital Hill and Hadley campuses.